Diagnosis and Treatment of Idiopathic Intracranial Hypertension (IIH) in Children and Adolescents

Headache (I Garza, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Headache


Idiopathic intracranial hypertension (IIH) is characterized by symptoms and signs of elevated intracranial pressure, elevated cerebrospinal fluid (CSF) pressure, normal CSF content, and normal brain with normal or small ventricles on neuroimaging studies. IIH in children has a wide spectrum of clinical presentation. Diagnostic criteria with modifications to adapt to the variations in children are discussed. Diagnostic and therapeutic options are reviewed.


Idiopathic intracranial hypertension Pseudotumor cerebri Papilledema Headache Opening pressure Visual deterioration Acetazolamide 



No potential conflicts of interest relevant to this article were reported.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Quincke H. Uber meningitis serora and verewandte zustande. Dtsch Z Nervenheil. 1897;9:149–68.CrossRefGoogle Scholar
  2. 2.
    Nonne M. Ueber Falle vom Symptomkomplex “tumor cerebri” mit Ausgang in Heilung. Dtsch Z Nervenheil. 1904;27:169–216.CrossRefGoogle Scholar
  3. 3.
    Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106:492–513.PubMedCrossRefGoogle Scholar
  4. 4.
    Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Balcer LJ, Liu GT, Forman S, Pun K, Volpe NJ, Galletta SL et al. Idiopathic intracranial hypertension: relationship of age and obesity in children. Neurology. 1999;52:870–2.Google Scholar
  6. 6.
    Binder DK, Horton HC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery. 2004;54:538–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Spennato P, Ruggiero C, Parlato RS, Buonocore MC, Varone A, Cianciuli E et al. Pseudotumor cerebri. Childs Nerv Syst. 2011;27:215–35.Google Scholar
  8. 8.
    Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;9:144–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. JAAPOS. 1998;2:33–8.Google Scholar
  10. 10.
    Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52:597–617.PubMedCrossRefGoogle Scholar
  11. 11.
    Phillips PH. Pediatric pseudotumor cerebri. Int Ophthalmol Clin. 2012;3:51–9.CrossRefGoogle Scholar
  12. 12.
    Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep. 2007;11:62–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Tibussek D, Schneider DT, Vandemeulebroecke N, Turowski B, Messing-Juenger M, Wilems P et al. Clinical spectrum of the pseudotumor cerebri complex in children. Childs Nerv Syst. 2010;26:313–21.Google Scholar
  14. 14.
    Per H, Canpolat M, Gumus H, Poyrazoglu HG, Yikilmaz A, Karakucuk S et al. Clinical spectrum of pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2012 (in press).Google Scholar
  15. 15.
    Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17:745–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Eldes NH, Yilmaz Y. Pseudotumor cerebri in children: etiological, clinical features, and treatment modalities. Eur J Paediatr Neurol. 2012;16:349–55.CrossRefGoogle Scholar
  17. 17.
    Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol. 1999;127:178–82.PubMedCrossRefGoogle Scholar
  18. 18.
    Bassan H, Berkner L. Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand. 2008;118:251–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Tan H. Bilateral oculomotor palsy secondary to pseudotumor cerebri. Pediatr Neurol. 2010;42:141–2.PubMedCrossRefGoogle Scholar
  20. 20.
    Tzoufi M, Makis A, Grammeniatis V, Nakou I, Exarchakos G, Asproudis I et al. Idiopathic intracranial hypertension and facial palsy: case report and review of literature. J Child Neurol. 2010;25:1529–34.Google Scholar
  21. 21.
    Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.PubMedCrossRefGoogle Scholar
  22. 22.
    • Avery RA, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363:891–3. This 2 year single-center perspective study of CSF opening pressure in children undergoing lumbar puncture had systematically defined reference range for CSF pressure in pediatric population. It suggested that an opening pressure of >280 mm H20 should be considered elevated in this age group.Google Scholar
  23. 23.
    •• Avery RA, Licht DJ, Shah SS, Huh JW, Seiden JA, Boswinkel J et al. CSF opening pressure in children with optic nerve head edema. Neurology. 2011;76:1658–61. This is a prospective comparative study that evaluated the range of opening pressure for children with optic nerve head edema and age-matched controls. It re-affirms the finding that an opening pressure of >280 mm H20 in children is abnormal. This also serves a basis to reconsider the diagnostic criteria for IIH pediatric age. Google Scholar
  24. 24.
    Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24:9–160.CrossRefGoogle Scholar
  25. 25.
    Lim MJ, Pushparajah K, Jan W, Calver D, Lin JP. Magnetic resonance imaging changes in idiopathic intracranial hypertension in children. J Child Neurol. 2010;25:294–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Shofty B, Ben-Sira L, Constantini S, Freedman S, Kesler A. Optic nerve sheath diameter on MR Imaging: establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. Am J Neuroradiol. 2012;33:366–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83:488–94.PubMedCrossRefGoogle Scholar
  28. 28.
    Ahmed R, Friedman DI, Halmagyi GM. Stenting of the tranverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;66:334–8.Google Scholar
  29. 29.
    Stienen A, Weinzierl M, Ludolph A, Tibussek D, Hausler M. Obstruction of the cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol. 2008;15:1416–8.Google Scholar
  30. 30.
    Standbridge SM, O’Brien SH. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation. J Child Neurol. 2008;23:1308–11.CrossRefGoogle Scholar
  31. 31.
    Standbridge SM. Idiopathic intracranial hypertension in children: a review and algorithm. Pediatr Neurol. 2010;43:377–90.CrossRefGoogle Scholar
  32. 32.
    Lee MW, Vedanarayanan VV. Cerebrospinal fluid opening pressure in children: experience in a controlled setting. Pediatr Neurol. 2011;45:238–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Warden KF, Alizai AM, Trobe JD, Hoff JT. Short term continuous intraparenchymal intracranial pressure monitoring in presumed idiopathic intracranial hypertension. J Neurol Ophthalmol. 2011;32:202–5.CrossRefGoogle Scholar
  34. 34.
    Toma AK, Tarnaris A, Kitchen ND, Watkins LD. Continuous intracranial pressure monitoring in pseudotumour cerebri: single center experience. Br J Neurosurg. 2010;24:584–8.Google Scholar
  35. 35.
    Avery RA, Mistry RD, Shah SS, Boswinkel J, Huh JW, Ruppe MD et al. Patient position during lumbar puncture has no meaningful effect on cerebrospinal fluid opening pressure in children. J Child Neurol. 2010;25:616–9.Google Scholar
  36. 36.
    Chern JJ, Tubbs RS, Gordon AS, Donnithorne KJ, Oakes WJ. Management of pediatric patients with pseudotumor cerebri. Child Nerv Syst. 2012;28:575–8.Google Scholar
  37. 37.
    Wolf A, Hutcheson KA. Advances in evaluation and management of pediatric idiopathic hypertension. Curr Opin Ophthalmol. 2008;19:391–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS et al. A randomized controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–81.Google Scholar
  39. 39.
    Matthews YY. Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed. 2008;93:19–25.PubMedCrossRefGoogle Scholar
  40. 40.
    Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology. 2005;112:724–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalmis Surg Lasers. 1998;29:514–7.Google Scholar
  43. 43.
    Koc K, Anik I. Endoscopic optic nerve decompression for idiopathic intracranial hypertension in 2 cases: case report. Minim Invas Neurosurg. 2008;51:72–5.CrossRefGoogle Scholar
  44. 44.
    Yazici Z, Yazici B, Tuncel E. Findings of magnetic resonance imaging after optic nerve sheath decompression in patients with idiopathic intracranial hypertension. Am J Ophthalmol. 2007;144:429–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Kandasamy J, Hayhurst C, Clark S, Jenkinson MD, Byrne P, Karabatsou K et al. Electromagnetic stereotactic ventriculoperitoneal CSF shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 2011;75:155–60.Google Scholar
  46. 46.
    Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site? A single center experience. Clin Neurol Neurosurg. 2011;113:477–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O’Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts- case series and literature review. Br J Neurosurg. 2011;25:94–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10 year review. Cephalalgia. 2011;31:1627–33.PubMedCrossRefGoogle Scholar
  49. 49.
    Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR. 2011;32:1408–14.Google Scholar
  50. 50.
    Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116:538–48.Google Scholar
  51. 51.
    Albuquerque FC, Dashti SR, Hu YC, Newman CB, Teleb M, McDougall CG et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 2011;75:648–52.Google Scholar
  52. 52.
    Bussiere M, Falero R, Nicolle D, Proulx A, Patel V, Pelz D. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR. 2010;31:645–50.Google Scholar
  53. 53.
    Rajpal S, Niemann DB, Turk AS. Transverse venous sinus stent placement as treatment for benign intracranial hypertension in a young male. J Neurosurg. 2005;102:342–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Curry WT, Butler WE, Barker FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the US, 1988–2002. Neurosurgery. 2005;57:97–107.PubMedCrossRefGoogle Scholar
  55. 55.
    Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol. 2012;259:886–94.PubMedCrossRefGoogle Scholar
  56. 56.
    Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Am J Ophthalmol. 2006;142:279–83.Google Scholar
  57. 57.
    Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst. 2011;27:1913–8.Google Scholar
  58. 58.
    Kesler A, Hadayer A, Goldhammer Y, Almoq Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology. 2004;63:1737–9.Google Scholar
  59. 59.
    De Simone R, Marano E, Nilo L, Briganti F, Esposito M, Ripa P. Idiopathic intracranial hypertension without headache. Cephalagia. 2006;26:1020–1.Google Scholar
  60. 60.
    Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51:245–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Akron Children’s HospitalAkronUSA
  2. 2.Cleveland ClinicClevelandUSA

Personalised recommendations